Wikipedia -WSS

Wikipedia

author：fashion 2025-09-03 11:49:31 - browse：1897

From 2017 to 2020, Stimwave implanted nearly 8,000 patients with nerve stimulators containing dummy pieces of plastic. Adobe

The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

STAT published new details about the Stimwave story in May, learning from former employees that Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The FDA weighs the risks of candy

hotspot

WSS

As JPM 2024 winds down, some health tech firms project optimism

DeSantis can now import cheaper drugs. But will Biden get credit?

Why Sanofi got shellacked over its spinoff

Biden's order seeks to regulate AI risk without stifling innovation

Physician subsidies by hospitals soar in wake of No Surprises Act

Senate panel to vote on hospitals, PBMs, prisoner care

leisure time

Wikipedia

Wikipedia

New air purifier tech could be key to improving indoor air quality

Physician subsidies by hospitals soar in wake of No Surprises Act

Sports medicine is finally prioritizing gender equality

New menopause drug shows promise in relief for hot flashes

Heart attack and stroke risk calculators need revising

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

United colonoscopy coverage change 'may cost lives,' doctors say

Hospitals warn Medicare's drug payment fix is ‘unlawful’

In Memoriam: Notable people who died in 2023

The nurse manager staffing crisis is hurting patients

Wikipedia

Testing for cancer recurrence creates a new limbo for patients

DeSantis can now import cheaper drugs. But will Biden get credit?

Idaho abortion case may prompt more restrictions in other states

Medtronic CEO on promising devices for diabetes, hypertension

Caregivers of transplant patients call for more support, training

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

focus

hotspot

focus

focus